Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Rock_nj	6/10/2009 1:37:38 PM
	of 78742

Novavax (NVAX) appears undervalued right now given that they might have a vaccine to prevent the H1N1 swine flu in coming months. I'm not sure how to value Novavax since they have virtually no revenunes at the moment, but that could change dramatically if their vaccine gets approval. Right now it is just trading on future prospects. If they start ramping up vaccine production, who knows where NVAX will be trading? I brought some for my IRA because I think eventually they will be selling vaccines by the bundles and their revenues and stock price will be much higher than a paltry $3/share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next